Showing results (901-910 of 1,180) with videos related to

Sort By:
Pageof 118
Physical Review Letters|April 20, 2004
Pseudomorphic growth of a single element quasiperiodic ultrathin film on a quasicrystal substrateJ Ledieu, J T Hoeft, D E Reid, et al.
Transfusion|April 26, 2005
A flexible array format for large-scale, rapid blood group DNA typingGhazala Hashmi, Tasmia Shariff, Michael Seul, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 11, 2018
Associations of perceived norms with intentions to learn genomic sequencing results: Roles for attitudes and ambivalenceAllecia E Reid, Jennifer M Taber, Rebecca A Ferrer, et al.
British Journal of Haematology|February 27, 2004
Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphismsNichola Cooper, Nancy M Heddle, Masja Haas, et al.
BMC Infectious Diseases|March 24, 2016
Chest radiograph reading and recording system: evaluation in frontline clinicians in ZambiaGerman Henostroza, Jennifer B Harris, Nzali Kancheya, et al.
JCO Precision Oncology|February 9, 2022
Homologous Recombination Deficiency in Patients With Pancreatic Ductal Adenocarcinoma and Response to ChemotherapySafi Shahda, Kirsten M Timms, Ashley A Ibrahim, et al.
American Journal of Epidemiology|February 24, 2006
Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trialSaverio Stranges, James R Marshall, Maurizio Trevisan, et al.
Nuclear Medicine and Biology|March 28, 2009
Evaluation of 6-([(18)F]fluoroacetamido)-1-hexanoicanilide for PET imaging of histone deacetylase in the baboon brainAlicia E Reid, Jacob Hooker, Elena Shumay, et al.
Anti-Cancer Drugs|September 23, 2003
Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy StudyM S Stratton, M E Reid, G Schwartzberg, et al.
Biochemical Pharmacology|December 20, 2005
Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compoundsS M Guichard, R Else, E Reid, et al.
Pageof 118